Related Experiment Video

Updated: May 9, 2026

Seven Steps to Stellate Cells
06:40

Seven Steps to Stellate Cells

Published on: May 10, 2011

[Role of macrophage migration inhibitory factor in hepatic stellate cells activation]

Yong-Jun Zhu1, Xiao-Lin Hu, Ruo-Ting Men

  • 1Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, China.

Abstract

Insights

Macrophage migration inhibitory factor (MIF) is upregulated during hepatic stellate cell (HSC) activation. Specific antisense oligonucleotides targeting MIF effectively inhibited HSC activation, suggesting MIF

Area of Science:

  • Hepatology
  • Cell Biology
  • Molecular Medicine

Background:

  • Hepatic stellate cells (HSCs) play a critical role in liver fibrosis.
  • Activation of HSCs is a key event in the pathogenesis of liver fibrosis.
  • Understanding the molecular mechanisms regulating HSC activation is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of macrophage migration inhibitory factor (MIF) in the activation of primary HSCs.
  • To explore the potential of MIF-specific antisense oligonucleotides (ASONs) to block HSC activation.

Main Methods:

  • Primary rat HSCs were isolated and cultured.
  • HSC activation was assessed by alpha-smooth muscle actin (alpha-SMA) expression.
  • MIF expression was measured using RT-PCR, ELISA, and immunocytochemistry.
  • Activated HSCs were transfected with MIF-specific ASONs, control ASONs, or liposomes.

Main Results:

  • MIF expression was significantly upregulated during HSC activation.
  • A strong positive correlation was observed between alpha-SMA and MIF expression.
  • MIF-ASONs treatment significantly reduced MIF and alpha-SMA expression in activated HSCs.

Conclusions:

  • MIF expression is upregulated during HSC activation.
  • MIF plays a significant role in HSC activation and potentially hepatic fibrosis.
  • MIF-specific ASONs demonstrate potential as a therapeutic strategy to inhibit HSC activation.